A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma (EVOLVE)
A Randomized Clinical Trial of ab Interno Canaloplasty and Trabeculotomy With the OMNI Surgical System Compared to Standard Medical Treatment as a Standalone Procedure in Patients With Primary Open Angle Glaucoma
Sponsor: Sight Sciences, Inc.
Terminated
Business decision by the Sponsor
Other terminated trials from Sight Sciences, Inc.
- Glaucoma, Open-Angle · Phase NA · Nov 2022
- Glaucoma, Open-Angle · Phase NA · Mar 2021
- Glaucoma, Open-Angle · Phase NA · Jan 2021
- Open-Angle Glaucoma · Phase NA · Jan 2019
- Dry Eye Syndromes · Phase NA · Dec 2018
More terminations from Sight Sciences, Inc.
This PHASE4 trial investigates Primary Open Angle Glaucoma and is currently terminated or withdrawn. Sight Sciences, Inc. leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Feb 2025 — Present [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Oct 2024 — Feb 2025 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sight Sciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .